Globe says Tilray Brands maintained at "buy" $$$$$$$$$$$$$$$The Globe and Mail reports in its Tuesday, Jan. 14, edition that Canaccord Genuity analyst Matt Bottomley has reaffirmed his "buy" recommendation for Tilray Brands. The Globe's David Leeder writes in the Eye On Equities column that Mr. Bottomley lowered his share target to $3 from $4 (all figures U.S.). Analysts on average target the shares at $2.02. Mr. Bottomley says in a note, "Overall, FQ2 came in just under consensus expectations for the period, although the company was able to achieve moderate rebounds in a number of its operating segments (most notably in its international cannabis and recently expanded Bev/Alcohol segment)." The Globe reported on April 11 that Mr. Bottomley continued to rate Tilray Brands "buy." The shares could then be had for $1.90. The Globe reported on Oct. 11 that ATB Capital Markets analyst Frederico Gomes was sticking with his "sector perform" recommendation for Tilray Brands.